• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Bullous Pemphigoid Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: The NetherlandsChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Multifaceted Role of IL-13 in Airway Remodeling
Type 2 Inflammation
3 min
expert video

Multifaceted Role of IL-13 in Airway Remodeling

Mucus Plugging as a Potential Target in Asthma Management
Type 2 Inflammation
3 min
expert video

Mucus Plugging as a Potential Target in Asthma Management

Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma
Type 2 Inflammation
5 min
expert video

Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma

ERS-ISIAN 2025 | Treatable Traits in CRSwNP
Rhinology
10 min
expert video

ERS-ISIAN 2025 | Treatable Traits in CRSwNP

ERS-ISIAN 2025 | Type 2 Inflammation: Links with Severe/Uncontrolled CRSwNP
Rhinology
10 min
expert video

ERS-ISIAN 2025 | Type 2 Inflammation: Links with Severe/Uncontrolled CRSwNP

ERS-ISIAN 2025 | Disease Control in CRSwNP
Rhinology
10 min
expert video

ERS-ISIAN 2025 | Disease Control in CRSwNP

KOL Video Interview – Dr. Eric Simpson
Dermatology
5 min
expert video

KOL Video Interview – Dr. Eric Simpson

Under the Itchy Surface: The Insidious, Cumulative Burden of Type 2 Inflammation in AD
Dermatology
5 min
expert video

Under the Itchy Surface: The Insidious, Cumulative Burden of Type 2 Inflammation in AD

How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?
Dermatology
4 min
expert video

How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?

EAACI 2025 | At The Intersection of the Type 2 Airways: Navigating the Challenges of CRSwNP & Co-existing Asthma
Type 2 Inflammation
11 min
expert video

EAACI 2025 | At The Intersection of the Type 2 Airways: Navigating the Challenges of CRSwNP & Co-existing Asthma

AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners
Type 2 Inflammation
45 min
videoanimation

AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners

Lung Function Decline: Why it Matters and What’s at Stake for Patients
Pulmonology
5 min
interactivity

Lung Function Decline: Why it Matters and What’s at Stake for Patients

    1
    ...
    8910
    ...
    29